Pharmacoeconomics analysis of two treatment schemes in decompensated cirrhosis pa-tients
10.3969/j.issn.1006-0111.2015.01.023
- VernacularTitle:2种保肝方案在肝硬化失代偿期治疗中的药物经济学评价
- Author:
Ying SUN
1
;
Jingwen WANG
;
Guobing SHI
Author Information
1. 沈阳药科大学
- Keywords:
cirrhosis;
decompensated period;
drug economics;
cost-effectiveness analysis;
protect liver scheme
- From:
Journal of Pharmaceutical Practice
2015;(1):80-82
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate two treatment schemes of liver protection and choose the optimal radiotherapy using phar‐macoeconomics principle and methods .Methods In‐patients who were diagnosed as decompensated cirrhosis patients and simultaneously conformed to the Chlid‐Pugh graduation of level B‐C during 2010-2012 were chosen .The chosen patients were divided into A ,B and C group separately ,and were treated with the compound prescription of dichloro acetic acid two isopropyl amine inoculation fluid ,the poly‐ene phosphatide acid radical choline inoculation fluid ,and the compound prescription dichloro acetic acid two isopropyl amine inoculation fluid and the polyene phosphatide acid radical choline inoculation fluid .Cost effectiveness analysis was done between group B and C .Re‐sults Treatment time of group B and C was (15 .5 ± 8 .55) d and (12 .13 ± 7 .61) d respectively .The total effectiveness was 50% and 60% respectively and the difference was with non‐statistics significance (P>0 .05) .The total cost was (1 640 .52 ± 905 .26) yuan and (2 576 .51 ± 1 615 .99) yuan respectively .Conclusion Group B was the better treatment scheme .
